Oncolytics Biotech Inc. (TSE:ONC – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$2.58 and traded as high as C$3.04. Oncolytics Biotech shares last traded at C$2.96, with a volume of 98,113 shares.
Analyst Upgrades and Downgrades
Separately, Jonestrading set a C$9.00 target price on shares of Oncolytics Biotech and gave the company a “buy” rating in a report on Wednesday, May 24th.
Oncolytics Biotech Trading Down 2.7 %
Oncolytics Biotech (TSE:ONC – Get Free Report) last announced its quarterly earnings results on Monday, August 14th. The company reported C($0.12) earnings per share for the quarter, meeting the consensus estimate of C($0.12). As a group, equities research analysts forecast that Oncolytics Biotech Inc. will post -0.41 EPS for the current fiscal year.
Oncolytics Biotech Company Profile
Oncolytics Biotech Inc, a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.
- Five stocks we like better than Oncolytics Biotech
- What is a Non-Fungible Token (NFT)? Definition and How it Works
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- What is a Low P/E Ratio and What Does it Tell Investors?
- MarketBeat Week in Review – 9/11 – 9/15
- How Can Investors Benefit From After-Hours Trading
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Oncolytics Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncolytics Biotech and related companies with MarketBeat.com's FREE daily email newsletter.